Asosiy kontentga oʻtish
Maqola

Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment

Saade Abdalkareem JasimMedical Laboratory Techniques Department, Al-Maarif University College, Anbar, IraqI.M. FarberDepartment of children's diseases of the F. Filatov clinical institute of children's health, I. M. Sechenov First Moscow State Medical University of Health of Russian Federation (Sechenov University), Moscow, RussiaSara Abdalrazzaq M. NoraldeenDepartment of Oncology and Metabolism, University of Tabuk, Tabuk, Saudi ArabiaPooja BansalDepartment of Biotechnology and Genetics, Jain (Deemed-to-be) University, Bengaluru, Karnataka 560069, IndiaHashem O. AlsaabDepartment of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 21944, Saudi ArabiaBekhzod AbdullaevResearch Department of Biotechnology, New Uzbekistan University, Mustaqillik Avenue 54, Tashkent 100007, Uzbekistan; Department of Oncology, School of Medicine, Central Asian University, Milliy Bog Street 264, Tashkent 111221, Uzbekistan.. Electronic address: [email protected]Adnan Taan AlkhafajiAl-Ayen UniversityAhmed AlawadiCollege of Technical Engineering, the Islamic University of Al Diwaniyah, Qadisiyyah, IraqHamza Fadhel HamzahDepartment of Medical Laboratories Technology, AL-Nisour University College, Baghdad, IraqBahira Abdulrazzaq MohammedDepartment of Technical Engineering, Al-Hadi University College, Baghdad 10011, Iraq
Microvascular Researchjournal2024en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Mavzular

Identifikatorlar

Iqtiboslar va manbalar